33 results on '"Tyagi, A. K."'
Search Results
2. Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype.
- Author
-
Rao V, Dhar N, Shakila H, Singh R, Khera A, Jain R, Naseema M, Paramasivan CN, Narayanan PR, Ramanathan VD, and Tyagi AK
- Subjects
- Animals, Antigens, Bacterial administration & dosage, Antigens, Bacterial biosynthesis, BCG Vaccine administration & dosage, Genetic Vectors administration & dosage, Guinea Pigs, Interleukin-10 biosynthesis, Lipoproteins administration & dosage, Lipoproteins genetics, Lung pathology, Mice, Mice, Inbred BALB C, Mycobacterium bovis genetics, Mycobacterium tuberculosis pathogenicity, Spleen immunology, Tuberculosis immunology, Tuberculosis pathology, Vaccines, Synthetic administration & dosage, BCG Vaccine immunology, Interferon-gamma biosynthesis, Mycobacterium bovis immunology, Mycobacterium tuberculosis immunology, Tuberculosis prevention & control, Vaccination
- Abstract
Mycobacterium tuberculosis can not only neutralize immune effector functions, but also has the ability to modulate host-signalling cascades involved in the development of these responses. The 19 kDa antigen (Rv3763), a lipoprotein of M. tuberculosis, elicits high levels of interleukin (IL)-12 from macrophages in addition to its powerful immunomodulatory properties, leading to suppression of antigen-presentation signalling cascades. The present study was aimed at analysing the effect of overexpression of this antigen on the immunostimulatory properties of M. bovis Bacille Calmette-Guerin (BCG). We have constructed a recombinant BCG strain (rBCG19N) producing higher levels of the 19 kDa antigen in both the cytoplasmic (approximately eightfold) and extracellular (approximately fivefold) fractions as compared to the wildtype BCG. Immunization of mice with rBCG19N elicited high levels of interferon-gamma (IFN-gamma) and relatively low levels of IL-10 against the purified 19 kDa antigen. However, in response to total BCG sonicate, mice immunized with rBCG19N produced significantly high levels of IL-10 with relatively very low levels of IFN-gamma. This polarization of the host immune responses towards T-helper 2 subtype resulted in complete abrogation of the protective efficacy of BCG, when rBCG19N was used as a live vaccine against M. tuberculosis challenge in guinea pigs.
- Published
- 2005
- Full Text
- View/download PDF
3. Challenges and Advances in TB Drug Discovery
- Author
-
Khare, Garima, Nangpal, Prachi, Tyagi, Anil K., Hasnain, Seyed Ehtesham, editor, Ehtesham, Nasreen Z., editor, and Grover, Sonam, editor
- Published
- 2019
- Full Text
- View/download PDF
4. Recent Advances in Tuberculosis Research in India
- Author
-
Tyagi, Anil K., Dhar, Neeraj, Scheper, T., editor, Babel, W., editor, Blanch, H. W., editor, Endo, I., editor, Enfors, S. -O., editor, Fiechter, A., editor, Hoare, M., editor, Mattiasson, B., editor, Sahm, H., editor, Schügerl, K., editor, Stephanopoulos, G., editor, von Stockar, U., editor, Tsao, D. T., editor, Villadsen, J., editor, Wandrey, C., editor, Zhong, J. -J., editor, Ghose, Tarun K., editor, Ghosh, Purnendu, editor, Basu, S. K., editor, Bhardwaj, D., editor, Chauhan, V. S., editor, Dhar, N., editor, Johri, B. N., editor, Khurana, J. P., editor, Mukhopadhyay, A., editor, Padmanaban, G., editor, Sharma, A., editor, Sharma, M., editor, Swarup, R., editor, Tyagi, A. K., editor, and Virdi, J. S., editor
- Published
- 2003
- Full Text
- View/download PDF
5. Vaccination strategies for tuberculosis
- Author
-
Mehta, Abhinav, Tyagi, Rajeev K., Goyal, Amit, Khatri, Kapil, Gupta, Prem N., and Vyas, S. P.
- Published
- 2007
6. Protection against tuberculosis: How close are we to a perfect vaccine?
- Author
-
Tyagi, Anil K. and Khera, Aparna
- Published
- 2004
7. Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis
- Author
-
Dhar, Neeraj, Rao, Vivek, and Tyagi, Anil K.
- Published
- 2004
- Full Text
- View/download PDF
8. Editorial: Nanomedicine in Infectious Diseases: Drug Delivery and Vaccines.
- Author
-
Marepally, Srujan, Sahu, Tejram, and Tyagi, Rajeev K.
- Subjects
COMMUNICABLE diseases ,NANOMEDICINE ,DRUGS ,VACCINES ,DRUG carriers - Published
- 2022
- Full Text
- View/download PDF
9. Development of the first oligonucleotide microarray for global gene expression profiling in guinea pigs: defining the transcription signature of infectious diseases
- Author
-
Jain Ruchi, Dey Bappaditya, and Tyagi Anil K
- Subjects
Microarray ,Guinea pig ,Transcriptional profile ,Infectious diseases ,Tuberculosis ,Biotechnology ,TP248.13-248.65 ,Genetics ,QH426-470 - Abstract
Abstract Background The Guinea pig (Cavia porcellus) is one of the most extensively used animal models to study infectious diseases. However, despite its tremendous contribution towards understanding the establishment, progression and control of a number of diseases in general and tuberculosis in particular, the lack of fully annotated guinea pig genome sequence as well as appropriate molecular reagents has severely hampered detailed genetic and immunological analysis in this animal model. Results By employing the cross-species hybridization technique, we have developed an oligonucleotide microarray with 44,000 features assembled from different mammalian species, which to the best of our knowledge is the first attempt to employ microarray to study the global gene expression profile in guinea pigs. To validate and demonstrate the merit of this microarray, we have studied, as an example, the expression profile of guinea pig lungs during the advanced phase of M. tuberculosis infection. A significant upregulation of 1344 genes and a marked down regulation of 1856 genes in the lungs identified a disease signature of pulmonary tuberculosis infection. Conclusion We report the development of first comprehensive microarray for studying the global gene expression profile in guinea pigs and validation of its usefulness with tuberculosis as a case study. An important gap in the area of infectious diseases has been addressed and a valuable molecular tool is provided to optimally harness the potential of guinea pig model to develop better vaccines and therapies against human diseases.
- Published
- 2012
- Full Text
- View/download PDF
10. An evaluation of liposome-based diagnostics of pulmonary and extrapulmonary tuberculosis.
- Author
-
Tandel, Nikunj, Joseph, Anish Z, Joshi, Aishwarya, Shrama, Priya, Mishra, Ravi PN, Tyagi, Rajeev K., and Bisen, Prakash S
- Abstract
Introduction: Tuberculosis (TB) is still one of the major global health threats and delayed diagnosis or misdiagnosis continues to fuel the global epidemic. The conventional diagnostic approaches have shortcomings that might hinder the process of diagnosis of the disease and ultimately affect the prognosis. Area covered: We emphasize on the process of the synthesis of liposomes, its physicochemical properties affecting the formulation and their utilization in the field of molecular diagnostics for TB. The review also sheds a light on other nanoparticle-based molecular diagnostic approaches for TB. Despite the advent of science, we are yet to have a diagnostic tool that is simple, rapid, sensitive, and specific, and most importantly, one that enables us to demarcate patients with active tuberculosis from those with quiescent lesions, prior vaccination, or other diseases. Expert opinion: The utility of liposomes for diagnostic purposes has been attempted so as to overcome the challenges posed by conventional diagnostic tools for TB. Through this review, we present insights into liposome formulation and selection processes, various studies that report the use of liposome-based diagnostic tools for TB, as well as the limitations associated with the same that can be improvised to make the technology more efficient. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
11. bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.
- Author
-
Kar, Ritika, Nangpal, Prachi, Mathur, Shubhita, Singh, Swati, and Tyagi, Anil K.
- Subjects
MYCOBACTERIUM tuberculosis ,BIOTIN ,IMMUNIZATION ,BACTERIAL growth ,DELETION mutation ,TUBERCULOSIS prevention ,ANIMAL models in research - Abstract
Owing to the devastation caused by tuberculosis along with the unsatisfactory performance of the Bacillus Calmette–Guérin (BCG) vaccine, a more efficient vaccine than BCG is required for the global control of tuberculosis. A number of studies have demonstrated an essential role of biotin biosynthesis in the growth and survival of several microorganisms, including mycobacteria, through deletion of the genes involved in de novo biotin biosynthesis. In this study, we demonstrate that a bioA mutant of Mycobacterium tuberculosis (MtbΔbioA) is highly attenuated in the guinea pig model of tuberculosis when administered aerogenically as well as intradermally. Immunization with MtbΔbioA conferred significant protection in guinea pigs against an aerosol challenge with virulent M. tuberculosis, when compared with the unvaccinated animals. Booster immunization with MtbΔbioA offered no advantage over a single immunization. These experiments demonstrate the vaccinogenic potential of the attenuated M. tuberculosis bioA mutant against tuberculosis. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
12. Prevalence of pulmonary tuberculosis in Wardha district of Maharashtra, Central India.
- Author
-
Narang, Pratibha, Mendiratta, Deepak K., Tyagi, Naresh K., Jajoo, Ullhas N., Tayade, Atul T., Parihar, Pratapsingh H., Narang, Rahul, Mishra, Pranav S., Anjinappa, Sharda M., and K. Chadha, Vineet
- Subjects
TUBERCULOSIS ,SPUTUM ,RADIOGRAPHY ,SYMPTOMS - Abstract
A house based survey was conducted during 2007–2009 in a representative sample of population in Wardha district implementing Directly Observed Treatment Short Course strategy for tuberculosis (TB) control since 2001. The objective was to estimate prevalence of bacillary pulmonary TB (PTB) in individuals aged 15 years or above, and to estimate trends in prevalence when compared to a previous survey carried out in mid 1980's. Two sputum samples (one spot, one early morning) collected from individuals having symptoms suggestive of PTB, history of previous anti-TB treatment (ATT) or abnormal pulmonary shadow on Mass Miniature Radiography (MMR) consistent with possibly or probably active tuberculosis were subjected to Ziehl–Neelsen microscopy and culture on Lowenstein–Jensen medium. Of 55,096 individuals registered into the survey, 50,332 (91.4%) were screened by interview for symptoms and history of ATT and/or by MMR. Of them, 4805 were eligible for sputum collection; both specimens were collected in 4285 (89.2%) and only one specimen in 27 (0.6%). A total of 86 bacillary cases were detected during the survey. Prevalence of bacillary PTB was estimated at 188.7 (140.3–236.9) per 100,000 populations. There was a decline of 61% in the prevalence of PTB over a period of 22 years. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
13. Gene cooption in Mycobacteria and search for virulence attributes: Comparative proteomic analyses of Mycobacterium tuberculosis, Mycobacterium indicus pranii and other mycobacteria.
- Author
-
Singh, Yadvir, Kohli, Sakshi, Sowpati, Divya Tej, Rahman, Syed Asad, Tyagi, Anil K., and Hasnain, Seyed E.
- Subjects
MYCOBACTERIUM tuberculosis ,MYCOBACTERIUM ,IMMUNOREGULATION ,TUBERCULOSIS vaccines ,PROTEIN expression ,VIRULENCE of bacteria ,ANTIGEN analysis - Abstract
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a leading infectious disease taking one human life every 15 s globally. Mycobacterium undergoes reductive evolution; the ancestors have bigger genome size and rich in metabolic pathways. Mycobacterium indicus pranii (MIP) is placed much above Mycobacterium tuberculosis (M.tb) in evolutionary scale and is a non-pathogenic, saprophytic mycobacterium. Our in silico comparative proteomic analyses of virulence factors of M.tb and their homologs in 12 different Mycobacterial species, including MIP, point toward gene cooption as an important mechanism in evolution of mycobacteria. We propose that adaptive changes in niche factors of non-pathogenic mycobacterium, together with novel gene acquisitions, are key players in the evolution of pathogenicity. Antigenic analyses between M.tb and MIP highlighted the importance of PE/PPE family in host immunomodulation, further supporting the likely potential of MIP as an effective vaccine against TB. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
14. Apurinic/Apyrimidinic Endonucleases of Mycobacterium tuberculosis Protect against DNA Damage but Are Dispensable for the Growth of the Pathogen in Guinea Pigs.
- Author
-
Puri, Rupangi Verma, Reddy, P. Vineel, and Tyagi, Anil K.
- Subjects
APURINIC acid ,MYCOBACTERIUM tuberculosis ,DNA damage ,GUINEA pigs as laboratory animals ,SURGICAL excision ,DEVELOPMENTAL biology - Abstract
In host cells, Mycobacterium tuberculosis encounters an array of reactive molecules capable of damaging its genome. Non-bulky DNA lesions are the most common damages produced on the exposure of the pathogen to reactive species and base excision repair (BER) pathway is involved in the repair of such damage. During BER, apurinic/apyrimidinic (AP) endonuclease enzymes repair the abasic sites that are generated after spontaneous DNA base loss or by the action of DNA glycosylases, which if left unrepaired lead to inhibition of replication and transcription. However, the role of AP endonucleases in imparting protection against DNA damage and in the growth and pathogenesis of M.tuberculosis has not yet been elucidated. To demonstrate the biological significance of these enzymes in M.tuberculosis, it would be desirable to disrupt the relevant genes and evaluate the resulting mutants for their ability to grow in the host and cause disease. In this study, we have generated M.tuberculosis mutants of the base excision repair (BER) system, disrupted in either one (MtbΔend or MtbΔxthA) or both the AP endonucleases (MtbΔendΔxthA). We demonstrate that these genes are crucial for bacteria to withstand alkylation and oxidative stress in vitro. In addition, the mutant disrupted in both the AP endonucleases (MtbΔendΔxthA) exhibited a significant reduction in its ability to survive inside human macrophages. However, infection of guinea pigs with either MtbΔend or MtbΔxthA or MtbΔendΔxthA resulted in the similar bacillary load and pathological damage in the organs as observed in the case of infection with wild-type M.tuberculosis. The implications of these observations are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
15. Disruption of Mycobactin Biosynthesis Leads to Attenuation of Mycobacterium tuberculosis for Growth and Virulence.
- Author
-
Reddy, P. Vineel, Puri, Rupangi Verma, Chauhan, Priyanka, Kar, Ritika, Rohilla, Akshay, Khera, Aparna, and Tyagi, Anil K.
- Subjects
MYCOBACTIN ,BIOSYNTHESIS ,MICROBIAL virulence ,TUBERCULOSIS ,MYCOBACTERIUM tuberculosis ,CONNECTIVE tissue cells - Abstract
Background. Low iron availability in the host upregulates the mbt gene cluster of Mycobacterium tuberculosis, which is responsible for mycobactin biosynthesis. However, the biological significance of mycobactins in the growth of this pathogen and in disease progression has not been elucidated.Methods. We have disrupted the mbtE gene (Rv2380c) in the mbt cluster to evaluate the importance of mycobactin biosynthesis in the growth and virulence of M. tuberculosis.Results. The mbtE mutant (MtbΔmbtE) was unable to synthesize mycobactins, displayed an altered colony morphology, and was attenuated for growth in broth culture and in macrophages. Transmission electron microscopy revealed that MtbΔmbtE displayed an altered cell wall permeability. The growth characteristics and colony morphology of MtbΔmbtE were similar to wild type when the medium was supplemented with mycobactins or when MtbΔmbtE was genetically complemented with the mbtE gene. Moreover, guinea pigs infected with MtbΔmbtE exhibited a significantly reduced bacillary load and histopathological damage in the organs, in comparison to M. tuberculosis–infected animals.Conclusions. This study highlights the importance of mycobactins in the growth and virulence of M. tuberculosis and establishes the enzymes of mycobactin biosynthesis as novel targets for the development of therapeutic interventions against tuberculosis. [ABSTRACT FROM PUBLISHER]
- Published
- 2013
- Full Text
- View/download PDF
16. Endonuclease IV Is the Major Apurinic/Apyrimidinic Endonuclease in Mycobacterium tuberculosis and Is Important for Protection against Oxidative Damage.
- Author
-
Puri, Rupangi Verma, Singh, Nisha, Gupta, Rakesh K., and Tyagi, Anil K.
- Subjects
ENDONUCLEASES ,MYCOBACTERIUM tuberculosis ,OXIDATIVE stress ,BACTERIAL diseases ,DNA damage ,BACTERIAL enzymes ,ENZYME kinetics - Abstract
During the establishment of an infection, bacterial pathogens encounter oxidative stress resulting in the production of DNA lesions. Majority of these lesions are repaired by base excision repair (BER) pathway. Amongst these, abasic sites are the most frequent lesions in DNA. Class II apurinic/apyrimidinic (AP) endonucleases play a major role in BER of damaged DNA comprising of abasic sites. Mycobacterium tuberculosis, a deadly pathogen, resides in the human macrophages and is continually subjected to oxidative assaults. We have characterized for the first time two AP endonucleases namely Endonuclease IV (End) and Exonuclease III (XthA) that perform distinct functions in M.tuberculosis. We demonstrate that M.tuberculosis End is a typical AP endonuclease while XthA is predominantly a 3′→5′ exonuclease. The AP endonuclease activity of End and XthA was stimulated by Mg
2+ and Ca2+ and displayed a preferential recognition for abasic site paired opposite to a cytosine residue in DNA. Moreover, End exhibited metal ion independent 3′→5′ exonuclease activity while in the case of XthA this activity was metal ion dependent. We demonstrate that End is not only a more efficient AP endonuclease than XthA but it also represents the major AP endonuclease activity in M.tuberculosis and plays a crucial role in defense against oxidative stress. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
17. Secreted Acid Phosphatase (SapM) of Mycobacterium tuberculosis Is Indispensable for Arresting Phagosomal Maturation and Growth of the Pathogen in Guinea Pig Tissues.
- Author
-
Puri, Rupangi Verma, Reddy, P. Vineel, and Tyagi, Anil K.
- Subjects
ACID phosphatase ,SECRETION ,MYCOBACTERIUM tuberculosis ,PHAGOSOMES ,PATHOGENIC microorganisms ,COMMUNICABLE diseases - Abstract
Tuberculosis (TB) is responsible for nearly 1.4 million deaths globally every year and continues to remain a serious threat to human health. The problem is further complicated by the growing incidence of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), emphasizing the need for the development of new drugs against this disease. Phagosomal maturation arrest is an important strategy employed by Mycobacterium tuberculosis to evade the host immune system. Secretory acid phosphatase (SapM) of M.tuberculosis is known to dephosphorylate phosphotidylinositol 3-phosphate (PI3P) present on phagosomes. However, there have been divergent reports on the involvement of SapM in phagosomal maturation arrest in mycobacteria. This study was aimed at reascertaining the involvement of SapM in phagosomal maturation arrest in M.tuberculosis. Further, for the first time, we have also studied whether SapM is essential for the pathogenesis of M.tuberculosis. By deleting the sapM gene of M.tuberculosis, we demonstrate that MtbΔsapM is defective in the arrest of phagosomal maturation as well as for growth in human THP-1 macrophages. We further show that MtbΔsapM is severely attenuated for growth in the lungs and spleen of guinea pigs and has a significantly reduced ability to cause pathological damage in the host when compared with the parental strain. Also, the guinea pigs infected with MtbΔsapM exhibited a significantly enhanced survival when compared with M.tuberculosis infected animals. The importance of SapM in phagosomal maturation arrest as well as in the pathogenesis of M.tuberculosis establishes it as an attractive target for the development of new therapeutic molecules against tuberculosis. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
18. Development of vaccines against tuberculosis.
- Author
-
Tyagi, Anil K., Nangpal, Prachi, and Satchidanandam, Vijaya
- Subjects
DRUG development ,TUBERCULOSIS ,IMMUNE response ,DRUG efficacy ,MYCOBACTERIA ,VACCINES ,IMMUNE system ,ANTIGENS - Abstract
Summary: Development of an effective vaccine against tuberculosis (TB) hinges on an improved understanding of the human immune responses to Mycobacterium tuberculosis. A successful vaccination strategy should be able to stimulate the appropriate arm of the immune system with concomitant generation of the memory cells. In the absence of a perfect strategy, while long term efforts of TB researchers continue to resolve the nature of protective immunity against TB and other related issues, the current approach, dictated by the urgency of a TB vaccine, employs available knowledge and technology to develop new TB vaccines and channel the promising ones to clinical trials. While Indian scientists have contributed in several areas towards the development of a TB vaccine, this review is an attempt to summarize their contributions mainly pertaining to the discovery of new antigens, immune responses elicited by antigens against TB and development of new vaccines and their evaluation in animal models. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
19. Latency Antigen α-Crystallin Based Vaccination Imparts a Robust Protection against TB by Modulating the Dynamics of Pulmonary Cytokines.
- Author
-
Dey, Bappaditya, Jain, Ruchi, Khera, Aparna, Gupta, Umesh D., Katoch, V. M., Ramanathan, V. D., and Tyagi, Anil K.
- Subjects
INTERLEUKINS ,TUBERCULOSIS ,CYTOKINES ,MYCOBACTERIUM bovis ,T cells ,FLOW cytometry ,DNA vaccines ,TUMOR necrosis factors - Abstract
Background: Efficient control of tuberculosis (TB) requires development of strategies that can enhance efficacy of the existing vaccine Mycobacterium bovis Bacille Calmette Guerin (BCG). To date only a few studies have explored the potential of latency-associated antigens to augment the immunogenicity of BCG. Methods/Principal Findings: We evaluated the protective efficacy of a heterologous prime boost approach based on recombinant BCG and DNA vaccines targeting α-crystallin, a prominent latency antigen. We show that ''rBCG prime - DNA boost'' strategy (R/D) confers a markedly superior protection along with reduced pathology in comparison to BCG vaccination in guinea pigs (565 fold and 45 fold reduced CFU in lungs and spleen, respectively, in comparison to BCG vaccination). In addition, R/D regimen also confers enhanced protection in mice. Our results in guinea pig model show a distinct association of enhanced protection with an increased level of interleukin (IL)12 and a simultaneous increase in immuno-regulatory cytokines such as transforming growth factor (TGF)b and IL10 in lungs. The T cell effector functions, which could not be measured in guinea pigs due to technical limitations, were characterized in mice by multi-parameter flow cytometry. We show that R/D regimen elicits a heightened multi-functional CD4 Th1 cell response leading to enhanced protection. Conclusions/Significance: These results clearly indicate the superiority of α-crystallin based R/D regimen over BCG. Our observations from guinea pig studies indicate a crucial role of IL12, IL10 and TGFβ in vaccine-induced protection. Further, characterization of T cell responses in mice demonstrates that protection against TB is predictable by the frequency of CD4 T cells simultaneously producing interferon (IFN)γ, tumor necrosis factor (TNF)α and IL2. We anticipate that this study will not only contribute toward the development of a superior alternative to BCG, but will also stimulate designing of TB vaccines based on latency antigens. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
20. The sigma factors of Mycobacterium tuberculosis: regulation of the regulators.
- Author
-
Sachdeva, Preeti, Misra, Richa, Tyagi, Anil K., and Singh, Yogendra
- Subjects
MYCOBACTERIUM tuberculosis ,PROTEIN kinases ,MYCOBACTERIA ,MICROBIAL virulence ,CELLS ,MYCOBACTERIAL diseases - Abstract
One of the important determinants of virulence of Mycobacterium tuberculosis is adaptation to adverse conditions encountered in the host cells. The ability of Mycobacterium to successfully adapt to stress conditions is brought about by the expression of specific regulons effected by a repertoire of σ factors. The induction and availability of σ factors in response to specific stimuli is governed by a complex regulatory network comprising a number of proteins, including σ factors themselves. A serine–threonine protein kinase-mediated signaling pathway adds another dimension to the mycobacterial σ factor regulatory network. This review highlights the recent advances in understanding mycobacterial σ factors, their regulation and contribution to bacterial pathogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
21. Enhanced and Enduring Protection against Tuberculosis by Recombinant BCG-Ag85C and Its Association with Modulation of Cytokine Profile in Lung.
- Author
-
Jain, Ruchi, Dey, Bappaditya, Dhar, Neeraj, Rao, Vivek, Singh, Ramandeep, Gupta, Umesh D., Katoch, V. M., Ramanathan, V. D., and Tyagi, Anil K.
- Subjects
TUBERCULOSIS ,TUBERCULOSIS vaccines ,CYTOKINES ,GUINEA pigs as laboratory animals ,BCG immunotherapy ,DRUG efficacy ,TUMOR necrosis factors ,PREVENTIVE medicine - Abstract
Background: The variable efficacy (0-80%) of Mycobacterium bovis Bacille Calmette Guréin (BCG) vaccine against adult tuberculosis (TB) necessitates development of alternative vaccine candidates. Development of recombinant BCG (rBCG) over-expressing promising immunodominant antigens of M. tuberculosis represents one of the potential approaches for the development of vaccines against TB. Methods/Principal Findings: A recombinant strain of BCG - rBCG85C, over expressing the antigen 85C, a secretory immunodominant protein of M. tuberculosis, was evaluated for its protective efficacy in guinea pigs against M. tuberculosis challenge by aerosol route. Immunization with rBCG85C resulted in a substantial reduction in the lung (1.87 log
10 , p<0.01) and spleen (2.36 log10 , p<0.001) bacillary load with a commensurate reduction in pathological damage, when compared to the animals immunized with the parent BCG strain at 10 weeks post-infection. rBCG85C continued to provide superior protection over BCG even when post-challenge period was prolonged to 16 weeks. The cytokine profile of pulmonary granulomas revealed that the superior protection imparted by rBCG85C was associated with the reduced levels of pro-inflammatory cytokines - interleukin (IL)-12, interferon (IFN)-γ, tumor necrosis factor (TNF)-α, moderate levels of anti-inflammatory cytokine - transforming growth factor (TGF)-β along with up-regulation of inducible nitric oxide synthase (iNOS). In addition, the rBCG85C vaccine induced modulation of the cytokine levels was found to be associated with reduced fibrosis and antigen load accompanied by the restoration of normal lung architecture. Conclusions/Significance: These results clearly indicate the superiority of rBCG85C over BCG as a promising prophylactic vaccine against TB. The enduring protection observed in this study gives enough reason to postulate that if an open-ended study is carried out with low dose of infection, rBCG85C vaccine in all likelihood would show enhanced survival of guinea pigs. [ABSTRACT FROM AUTHOR]- Published
- 2008
- Full Text
- View/download PDF
22. Mechanistic Insights into a Novel Exporter-Importer System of Mycobacterium tuberculosis Unravel Its Role in Trafficking of Iron.
- Author
-
Farhana, Aisha, Kumar, Sandeep, Rathore, Shailendra S., Ghosh, Prahlad C., Ehtesham, Nasreen Z., Tyagi, Anil K., and Hasnain, Seyed E.
- Subjects
MYCOBACTERIUM tuberculosis ,MYCOBACTERIAL diseases ,PATHOGENIC microorganisms ,TUBERCULOSIS ,IRON ,PROTEINS ,BIOSYNTHESIS ,SIDEROPHORES ,GENES - Abstract
Background: Elucidation of the basic mechanistic and biochemical principles underlying siderophore mediated iron uptake in mycobacteria is crucial for targeting this principal survival strategy vis-a`-vis virulence determinants of the pathogen. Although, an understanding of siderophore biosynthesis is known, the mechanism of their secretion and uptake still remains elusive. Methodology/Principal Findings: Here, we demonstrate an interplay among three iron regulated Mycobacterium tuberculosis (M.tb) proteins, namely, Rv1348 (IrtA), Rv1349 (IrtB) and Rv2895c in export and import of M.tb siderophores across the membrane and the consequent iron uptake. IrtA, interestingly, has a fused N-terminal substrate binding domain (SBD), representing an atypical subset of ABC transporters, unlike IrtB that harbors only the permease and ATPase domain. SBD selectively binds to non-ferrated siderophores whereas Rv2895c exhibits relatively higher affinity towards ferrated siderophores. An interaction between the permease domain of IrtB and Rv2895c is evident from GST pull-down assay. In vitro liposome reconstitution experiments further demonstrate that IrtA is indeed a siderophore exporter and the twocomponent IrtB-Rv2895c system is an importer of ferrated siderophores. Knockout of msmeg_6554, the irtA homologue in Mycobacterium smegmatis, resulted in an impaired M.tb siderophore export that is restored upon complementation with M.tb irtA. Conclusion: Our data suggest the interplay of three proteins, namely IrtA, IrtB and Rv2895c in synergizing the balance of siderophores and thus iron inside the mycobacterial cell. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
23. Deciphering the genes involved in pathogenesis of Mycobacterium tuberculosis.
- Author
-
Singh, Ramandeep, Singh, Amit, and Tyagi, Anil K
- Subjects
MYCOBACTERIAL diseases ,LUNG diseases ,TUBERCULOSIS ,CHEST diseases - Abstract
Summary: We had previously reported identification of the virS gene of Mycobacterium tuberculosis (Rv3082c) belonging to the AraC family of transcriptional regulators. The 7 genes (Rv3083–Rv3089) which are present divergently to virS (Rv3082c) constitute an operon designated as the mymA operon. Further investigation on the regulation of this operon showed that transcription of the mymA operon is dependent on the presence of VirS protein. A 4-fold induction of the mymA operon promoter occurs specifically in the wild type M. tuberculosis and not in the virS mutant of M. tuberculosis (M.tbΔvirS) when exposed to acidic pH. Expression of the mymA operon was also induced in infected macrophages by ten-fold over a six-day period. Bioinformatic analysis suggested the involvement of these proteins in the modification of fatty acids required for cell envelope. This was supported by altered colony morphology and cell envelope structure and increased accumulation of C24/C26 fatty acids by M.tbΔvirS in comparison to the wild type strain. Thus, induction of mymA operon can play an important role in remodeling the envelope of intracellular M. tuberculosis under acidic conditions. Genomic analysis of M. tuberculosis revealed the presence of two tyrosine phosphatase genes—mptpA (Rv2234) and mptpB (Rv0153c). We have characterized both the tyrosine phosphatases of M. tuberculosis. To evaluate the role of MptpB in the pathogenesis of M. tuberculosis we have disrupted mptpB in the genome of M. tuberculosis. The wild type as well as mptpB mutant strain were comparable in their ability to infect and survive in the resting macrophages. However, the mptpB mutant strain was more sensitive to killing as compared to the wild type strain by IFN-γ activated macrophages. In guinea pig model of tuberculosis an approximately 70-fold reduced bacillary load was observed in the spleen of the animals infected with mptpB mutant strain as compared to the bacillary load in animals infected with the wild type strain at 6 weeks post-infection. These results suggest that mymA operon as well as mptpB gene of M. tuberculosis play an important role in the survival of the pathogen in the host. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
24. Nucleoside diphosphate kinase of Mycobacterium tuberculosis acts as GTPase-activating protein for Rho-GTPases
- Author
-
Chopra, Puneet, Koduri, Harshavardhan, Singh, Ramandeep, Koul, Anil, Ghildiyal, Megha, Sharma, Kirti, Tyagi, Anil K., and Singh, Yogendra
- Subjects
MYCOBACTERIAL diseases ,LUNG diseases ,TUBERCULOSIS ,CULTURE - Abstract
Several bacterial pathogens secrete proteins into the host cells that act as GTPase-activating proteins (GAPs) for Rho-GTPases and convert GTP-bound active form to GDP-bound inactive form. However, no such effector molecule has been identified in Mycobacterium tuberculosis. In this study, we show that culture supernatant of M. tuberculosis H
37 Rv harbors a protein that stimulates the conversion of GTP-bound Rho-GTPases to the GDP-bound form. Nucleoside diphosphate kinase (Ndk) was identified as this culture supernatant protein that stimulated in vitro GTP hydrolysis by members of Rho-GTPases. The histidine-117 mutant of Ndk, which is impaired for autophosphorylation and nucleotide-binding activities, shows GAP activity. These results suggest that Ndk of M. tuberculosis functions as a Rho-GAP to downregulate Rho-GTPases, and this activity may aid in pathogenesis of the bacteria. [Copyright &y& Elsevier]- Published
- 2004
- Full Text
- View/download PDF
25. mymA operon of Mycobacterium tuberculosis: its regulation and importance in the cell envelope
- Author
-
Singh, Amit, Jain, Shruti, Gupta, Seema, Das, Taposh, and Tyagi, Anil K.
- Subjects
MYCOBACTERIUM tuberculosis ,GENE expression ,OPERONS - Abstract
Mycobacterium tuberculosis faces various stressful conditions inside the host and responds to them through a coordinated regulation of gene expression. We had previously reported identification of the virS gene of M. tuberculosis (Rv3082c) belonging to the AraC family of transcriptional regulators. In the current study, we show that the seven genes (Rv3083–Rv3089) which are present divergently to virS (Rv3082c) constitute an operon designated the mymA operon. Further investigation on the regulation of this operon showed that transcription of the mymA operon is dependent on the presence of VirS protein. A four-fold induction of the mymA operon promoter occurs specifically in wild-type M. tuberculosis and not in the virS mutant of M. tuberculosis (MtbΔvirS) when exposed to acidic pH. Expression of the mymA operon was also induced in infected macrophages by 10-fold over a 6-day period. To gain an insight into the function of the proteins encoded by this operon, we carried out a bioinformatic analysis, which suggested the involvement of these proteins in the modification of fatty acids required for cell envelope. This was supported by altered colony morphology and cell envelope structure displayed by the virS mutant of M. tuberculosis (MtbΔvirS). [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
26. Cytotoxic activity of nucleoside diphosphate kinase secreted from Mycobacterium tuberculosis.
- Author
-
Chopra, Puneet, Singh, Anubha, Koul, Anil, Ramachandran, S., Drlica, Karl, Tyagi, Anil K., and Singh, Yogendra
- Subjects
CELL-mediated cytotoxicity ,MYCOBACTERIUM ,NUCLEOSIDES ,TUBERCULOSIS ,GUANOSINE triphosphatase - Abstract
Pathogenicity of Mycobacterium tuberculosis is closely related to its ability to survive and replicate in the hostile environment of macrophages. For some pathogenic bacteria, secretion of ATP-utilizing enzymes into the extracellular environment aids in pathogen survival via P2Z receptor-mediated, ATP-induced death of infected macrophages. A component of these enzymes is nucleoside diphosphate kinase (Ndk). The ndk gene was cloned from M. tuberculosis H
37 Rv and expressed in Escherichia coli. Ndk was secreted into the culture medium by M. tuberculosis , as determined by enzymatic activity and Western blotting. Purified Ndk enhanced ATP-induced macrophage cell death, as assayed by the release of [14 C]adenine. A catalytic mutant of Ndk failed to enhance ATP-induced macrophage cell death, and periodate-oxidized ATP (oATP), an irreversible inhibitor of P2Z receptor, blocked ATP/Ndk-induced cell death. Purified Ndk was also found to be autophosphorylated with broad specificity for all nucleotides. Conversion of His117→Gln, which is part of the nucleotide-binding site, abolished autophosphorylation. Purified Ndk also showed GTPase activity. Collectively, these results indicate that secreted Ndk of M. tuberculosis acts as a cytotoxic factor for macrophages, which may help in dissemination of the bacilli and evasion of the immune system. [ABSTRACT FROM AUTHOR]- Published
- 2003
- Full Text
- View/download PDF
27. Skewing of the Th1/Th2 responses in mice due to variation in the level of expression of an antigen in a recombinant BCG system
- Author
-
Dhar, Neeraj, Rao, Vivek, and Tyagi, Anil K.
- Subjects
- *
MYCOBACTERIA , *TUBERCULOSIS , *TH1 cells , *IMMUNE response - Abstract
In spite of rapid developments in the study of mycobacteria during the last two decades, tuberculosis (TB) has maintained its status as the leading killer among all infectious diseases. Extensive evidence exists to support a central role for a T-helper type 1 (Th1) immune response for protection against TB in mice and humans. Bacille Calmette-Guerin (BCG), the only vaccine against TB, although not perfect in its ability to protect against the adult form of TB, is a strong inducer of Th1 responses and is being increasingly used as a delivery vehicle for the presentation of foreign antigens to the immune system. It has been proposed that expression of immunodominant antigens or cytokine genes in BCG can enhance the ability of BCG to induce a Th1 immune response. Since dose of the antigen is considered as one of the parameters that influence the Th cell responses, the level of expression of the candidate antigen should influence the final Th response against the recombinant BCG (rBCG). In the present study, the effect of over-expression of a candidate antigen Antigen 85B (Ag 85B) in a rBCG system, on the Th-priming ability of BCG has been investigated in the murine model. BALB/c mice were immunized with three different rBCG constructs expressing Ag 85B to various levels. Induction of Th1/Th2 responses was analyzed by measuring levels of interferon-γ (Th1) and interleukin-10 (Th2) in antigen-stimulated splenocyte cultures and by quantifying the antigen-specific IgG2a (Th1) and IgG1 (Th2) antibody responses. By varying the level of expression of Ag 85B, specific immune responses against Ag 85B were observed to range from mixed Th1/Th2 to Th1. However, the BCG-specific immune responses in case of all rBCG-immunized animals remained predominantly Th1. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
28. Serine/threonine protein kinases PknF and PknG of Mycobacterium tuberculosis: characterization and localization.
- Author
-
Koul, Anil, Choidas, Axel, Tyagi, Anil K., Drlica, Karl, Singh, Yogendra, and Ullrich, Axel
- Subjects
- *
SERINE proteinases , *TUBERCULOSIS - Abstract
Examines the localization of serine/threonin protein kinase F (pknF) and protein kinase G (pknG) of Myobacterium tuberculosis. Pathogenesis of M. tuberculosis; Analysis of pknF and pknG in other mycobacterial strains; Phosphorylation of proteins at specific amino acid residues.
- Published
- 2001
- Full Text
- View/download PDF
29. Development of novel carrier(s) mediated tuberculosis vaccine: More than a tour de force.
- Author
-
Garg, Neeraj K., Dwivedi, Priya, Jain, Ashay, Tyagi, Shikha, Sahu, Tejram, and Tyagi, Rajeev K.
- Subjects
- *
DRUG development , *TUBERCULOSIS vaccines , *INFECTIOUS disease transmission , *BCG immunotherapy , *MULTIDRUG resistance , *HEALTH outcome assessment - Abstract
Despite worldwide availability of the vaccines against most of the infectious diseases, BCG and various programs such as Directly Observed Treatment Short course (DOTS) to prevent tuberculosis still remains one of the most deadly forms of the disease affecting millions of people globally. The evolution of multi drug resistant strains (MDR) has increased the complexity further. Although currently available marketed BCG vaccine has shown sufficient protection against childhood tuberculosis, it has failed to prevent the most common form of disease i.e., pulmonary tuberculosis in adults. However, various vaccine candidates have already entered phase I clinical trials and have shown promising outcomes. The most prominent amongst them is the heterologous prime-boost approach, which shows a great promise towards designing and development of a new efficacious tuberculosis vaccine. It has also been shown that the use of various viral and non-viral vectors as carriers for the potential vaccine candidates will further boost their effect on subsequent immunization. In this review, we briefly summarize the potential of a few novel nano-carriers for developing effective vaccination strategies against tuberculosis. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
30. Over-expression of superoxide dismutase obliterates the protective effect of BCG against tuberculosis by modulating innate and adaptive immune responses
- Author
-
Jain, Ruchi, Dey, Bappaditya, Khera, Aparna, Srivastav, Priyadarshani, Gupta, Umesh D., Katoch, V.M., Ramanathan, V.D., and Tyagi, Anil K.
- Subjects
- *
GENE expression , *SUPEROXIDE dismutase , *BCG vaccines , *TUBERCULOSIS vaccines , *IMMUNE response , *NATURAL immunity , *RECOMBINANT viruses , *LABORATORY mice - Abstract
Abstract: An efficient global control of tuberculosis requires development of alternative vaccination strategies that can enhance the efficacy of existing BCG vaccine. In this study, we evaluated the protective efficacy of a recombinant BCG (rBCG) vaccine over-expressing iron-cofactored superoxide dismutase (SOD-A), one of the prominent oxidative stress response proteins of Mycobacterium tuberculosis. Contrary to our expectations, over-expression of SOD-A resulted in the abrogation of BCG''s ability to confer protection in guinea pig as well as in murine model. Analysis of immune responses revealed that over-expression of SOD-A by rBCG has pleiotropic effects on innate and adaptive immune responses. Macrophages infected in vitro with rBCG exhibited a marked reduction in apoptosis and microbicidal potential. In addition, rBCG vaccination of mice resulted in a reduced IFNγ and increased IL10 production when compared with the BCG vaccination. Further, we show that rBCG vaccination failed to generate an effective multi-functional CD4 T cell response. Altogether, our findings suggest that over-expression of SOD-A in BCG enhances the immuno-suppressive properties of BCG, characterized by skewing of immune responses towards Th2 type, an inefficient multi-functional T cell response and reduced apoptosis and microbicidal potential of macrophages leading to abolishment of BCG''s protective efficacy. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
31. Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs
- Author
-
Dey, Bappaditya, Jain, Ruchi, Khera, Aparna, Rao, Vivek, Dhar, Neeraj, Gupta, Umesh D., Katoch, V.M., Ramanathan, V.D., and Tyagi, Anil K.
- Subjects
- *
DNA vaccines , *GENE expression , *BCG vaccines , *MYCOBACTERIUM tuberculosis , *BACTERIAL vaccines , *VACCINATION , *GUINEA pigs as laboratory animals , *AEROSOLS , *BACTERIAL antigens , *TUBERCULOSIS vaccines , *DRUG development - Abstract
Abstract: Owing to its highly immunodominant nature and ability to induce long-lived memory immunity, ESAT-6, a prominent antigen of Mycobacterium tuberculosis, has been employed in several approaches to develop tuberculosis vaccines. Here, for the first time, we combined ESAT-6 based recombinant BCG (rBCG) and DNA vaccine (DNAE6) in a prime boost approach. Interestingly, in spite of inducing an enhanced antigen specific IFN-γ response in mice, a DNAE6 booster completely obliterated the protection imparted by rBCG against tuberculosis in guinea pigs. Analysis of immunopathology and cytokine responses suggests involvement of an exaggerated immunity behind the lack of protection imparted by this regimen. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
32. Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis
- Author
-
Khera, Aparna, Singh, Ramandeep, Shakila, H., Rao, Vivek, Dhar, Neeraj, Narayanan, P.R., Parmasivan, C.N., Ramanathan, V.D., and Tyagi, Anil K.
- Subjects
- *
VACCINES , *VACCINATION , *DNA vaccines , *IMMUNIZATION - Abstract
Abstract: DNA vaccination is an effective method for elicitation of strong humoral as well as cellular immune responses. DNA vaccines expressing mycobacterial antigens ESAT-6 (Rv3875), α-crystallin (Rv2031c) and superoxide dismutase A (Rv3846) were evaluated for their immune responses in Balb/c mice and protective efficacy in guinea pigs. Immunization of mice with the DNA vaccines expressing superoxide dismutase A and α-crystallin resulted in markedly higher levels of IFN-γ as compared to the levels of IL-10. The DNA vaccine expressing ESAT-6 elicited a mixed Th1/Th2 response. Immunization of guinea pigs with these DNA vaccines and subsequent challenge of animals with Mycobacterium tuberculosis H37Rv, showed that DNA vaccine expressing superoxide dismutase imparted the maximum protection as observed by a 50 and 10 folds reduction in bacillary load in spleens and lungs, respectively, in comparison to immunization with vector control. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
33. Inhibition of ABCG2 efflux pumps renders the Mycobacterium tuberculosis hiding in mesenchymal stem cells responsive to antibiotic treatment.
- Author
-
Kaur, Simran, Angrish, Nupur, Gupta, Kajal, Tyagi, Anil K., and Khare, Garima
- Subjects
- *
MESENCHYMAL stem cells , *EFFLUX (Microbiology) , *MYCOBACTERIUM tuberculosis , *ANTIBIOTICS , *PUMPING machinery , *BONE marrow , *DRUG administration - Abstract
The lengthy TB chemotherapeutic regimen, resulting in the emergence of drug resistance strains, poses a serious problem in the cure of the disease. Further, one-quarter of the world's population is infected with dormant M.tb , which creates a lifetime risk of reactivation. M.tb has a remarkable tendency to escape the host immune responses by hiding in unconventional niches. Recent studies have shown that bone-marrow mesenchymal stem cells (BM-MSCs) can serve as a reservoir of the pathogen and have been suggested to keep them beyond the reach of anti-TB drugs. In this study, we have shown that M.tb infects and grows inside BM-MSCs and were unresponsive to the anti-TB drugs rifampicin and isoniazid when compared to the pathogen residing inside THP-1 macrophages. It was further shown that the ABCG2 efflux pumps of the BM-MSCs were upregulated upon exposure to rifampicin, which may be the contributing factor for the antibiotic unresponsiveness of the bacteria inside these cells. Subsequently, it was shown that inhibition of ABCG2 efflux pumps along with administration of anti-TB drugs led to an increased susceptibility and consequently an enhanced killing of the M.tb inside BM-MSCs. These findings for the first time show that the MIC 99 values of anti-TB drugs increase many folds for the M.tb residing in BM-MSCs as compared to M.tb residing inside macrophages and the involvement of ABCG2 efflux pumps in this phenomenon. Our study substantiates that these BM-MSCs acts as a useful niche for M.tb wherein they can survive by escaping the antibiotic assault that can be attributed to the host ABCG2 efflux pumps. Inhibiting these efflux pumps can be an attractive adjunctive chemotherapy to eliminate the bacteria from this protective niche. Unlabelled Image • M.tb survives in mouse bone marrow derived mesenchymal stem cells (BM-MSCs). • M.tb inside BM-MSCs were unresponsive to anti-TB drugs rifampicin and isoniazid. • ABCG2 efflux pumps get upregulated upon exposure to rifampicin in BM-MSCs. • Inhibiting ABCG2 efflux pumps augmented rifampicin's effect on M.tb inside BM-MSCs. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.